Browse drugs

…licated autoimmune disease characterized by recurrent relapses. Belimumab (BEL) is a humanized monoclonal antibody and has been approved …

…A, anti Ro52 and low titer of IgM-RF) is initially treated with hydroxychloroquine, azathioprine and topical steroids. Because of insufficient imp…

…ow (see section on Current treatments). The antifibrotic drugs, pirfenidone and nintedanib, are established treatments for idiopathic pulmo…

…). Conventional immunosuppressants (methotrexate, azathioprine, mycophenolate mofetil) were not associated with reduced relapse risk, whereas belimum…

…Objective To assess the effectiveness of belimumab (BEL) in improving anaemia, thrombocytopenia, lymphopenia and l…

…arthritis was the most frequent diagnosis (30%).Drugs involved: adalimumab (35%), etanercept (25%), certolizumab (8%), belimumab (6%), ixe…

…e of pathogenic ASCs and sustain low disease activity following daratumumab treatment.…

…tologic (lymphopenia), and serologic activity (SLEDAI-2K 6–8 on prednisolone 10 mg/day).Results In August 2024, anifrolumab 300 mg IV monthl…

… was used in 68.8% vs 52.9%, Anifrolumab in 12.5% vs 35.3%, and Rituximab in 18.8% vs 11.8% (early vs late).The most frequent clinical ma…

…11), antimalarials (n= 55), tacrolimus (n= 27), everolimus (1), belimumab (BLM) (19) and anifrolumab (1). After a follow-up of 59.7±46 mo…

…CR 2019, SLICC and/or ACR 1997 diagnostic criteria treated with Belimumab in monotherapy. Data were collected from medical records of SLE…

…Objective To evaluate the effect of early belimumab administration on disease progression in patients with early ac…